Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
SynAct Pharma AB (8F8) Stock Price & Analysis
0 Followers
8F8 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.49 - €9.87
Previous Close€0.67
Volume0.00
Average Volume (3M)380.00
Market Cap
€28.63M
Enterprise Value€19.50M
Total Cash (Recent Filing)kr108.25M
Total Debt (Recent Filing)kr2.06M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Aug 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding35,570,980
10 Day Avg. Volume0
30 Day Avg. Volume380
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8F8 FAQ
What was SynAct Pharma AB’s price range in the past 12 months?
SynAct Pharma AB lowest stock price was €0.49 and its highest was €9.87 in the past 12 months.
What is SynAct Pharma AB’s market cap?
Currently, no data Available
When is SynAct Pharma AB’s upcoming earnings report date?
SynAct Pharma AB’s upcoming earnings report date is Aug 20, 2024 which is in 26 days.
How were SynAct Pharma AB’s earnings last quarter?
Currently, no data Available
Is SynAct Pharma AB overvalued?
According to Wall Street analysts SynAct Pharma AB’s price is currently Overvalued.
Does SynAct Pharma AB pay dividends?
SynAct Pharma AB does not currently pay dividends.
What is SynAct Pharma AB’s EPS estimate?
SynAct Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SynAct Pharma AB have?
SynAct Pharma AB has 41,296,463 shares outstanding.
What happened to SynAct Pharma AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SynAct Pharma AB?
Currently, no hedge funds are holding shares in DE:8F8
---
SynAct Pharma AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
SynAct Pharma AB
SynAct Pharma AB is engaged in the research and development of drugs for the treatment of psoriatic arthritis. It has developed a platform technology based on a new class of drug candidates directed against acute exacerbations of inflammatory diseases.
---
Technical Analysis
---